| ASSET | MONTH | % RETURN |
|---|---|---|
Maase (MAAS) | October 2024 | -65.08% |
Capri (CPRI) | October 2024 | -54.06% |
TransMedics (TMDX) | October 2024 | -47.12% |
Lucid (LCID) | October 2024 | -37.22% |
Acadia Healthcare (ACHC) | October 2024 | -32.23% |
Constellium (CSTM) | October 2024 | -32.07% |
Wingstop (WING) | October 2024 | -31.06% |
CVR Energy (CVI) | October 2024 | -30.29% |
Qorvo (QRVO) | October 2024 | -29.83% |
Tango Therapeutics (TNGX) | October 2024 | -29.42% |
Tyra Biosciences (TYRA) | October 2024 | -28.99% |
10X Genomics (TXG) | October 2024 | -28.91% |
Penguin Solutions (PENG) | October 2024 | -28.16% |
Nanobiotix (NBTX) | October 2024 | -27.78% |
Dana (DAN) | October 2024 | -27.3% |
Option Care Health (OPCH) | October 2024 | -26.55% |
Enphase Energy (ENPH) | October 2024 | -26.55% |
SolarEdge Technologies (SEDG) | October 2024 | -25.6% |
Crocs (CROX) | October 2024 | -25.18% |
Boot Barn (BOOT) | October 2024 | -25.07% |
UWM (UWMC) | October 2024 | -24.77% |
Wayfair (W) | October 2024 | -23.5% |
Celldex Therapeutics (CLDX) | October 2024 | -23.22% |
ICON (ICLR) | October 2024 | -22.69% |
Ermenegildo Zegna (ZGN) | October 2024 | -22.29% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.